Le Lézard
Classified in: Health, Business
Subjects: TDS, PSF, FVT

World Bosai Forum/International Disaster and Risk Conference 2017 to Be Held in Sendai, Japan, on November 25-28


SENDAI, Japan, Oct. 12, 2017 /PRNewswire/ -- The First World Bosai Forum/International Disaster and Risk Conference is going to be held from November 25 to 28, 2017, in Sendai, Japan. With the participation of diverse experts and citizens, lessons learned from the 2011 Great East Japan Earthquake will be conveyed. The most recent findings and developments of science and technology for disaster risk reduction will be presented, and new solutions for building a more resilient society will be proposed. Participants of study tours and excursions will experience the charms of the Tohoku region as well as the current situation in the disaster-affected areas. Please come and join us for this unique and inventive Forum.

(Photo: http://prw.kyodonews.jp/opn/release/201710106601/?images)

(Logo: http://prw.kyodonews.jp/img/201710106601-O1-pCE9M5Kd)

Forum Venue:

Sendai International Center and Kawauchi Hagi Hall, Tohoku University, Japan

Organizer:

World Bosai Forum Committee (Committee member organizations: Tohoku University, City of Sendai, Miyagi Prefectural Government, Kahoku Shimpo Publishing Co., Tohoku Economic Federation, Global Risk Forum GRF Davos, Sendai Chamber of Commerce and Industry)

Highlights

-Public Cultural Event, November 25:

Disaster risk reduction activities of the young generation will be presented. Performances of folk arts and music which have played important roles in the recovery of disaster areas will be provided. The audience will be able to experience the vitality of Tohoku which was severely damaged by the disaster but has been recovering.

-Sessions, November 26-28:

Approximately 50 sessions will be held. Diverse experts from industry, government, academia and private sectors will discuss the latest disaster-related issues and propose solutions for disaster risk reduction. Topics include AI, drones, a disaster statistics global database, mental health, nursing, investment, gender, nuclear energy, marine ecosystems, assessing tsunami damage, volunteer activities, and more.

-Study tours/excursions, November 26-29:

Participants will see how disaster areas have been recovered, and how society is building back better. Excursions will offer opportunities to enjoy the beautiful coastal areas of Tohoku.

For more information and registration, visit the website: www.worldbosaiforum.com/english/
Discounted early pre-registration will be possible until October 16 (JST11:59 a.m.)

* Bosai is a traditional Japanese term, indicating a holistic approach to reduce human and economic losses from disasters, which represents activities in all disaster phases, including prevention, recovery, response and mitigation.

SOURCE Tohoku University


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: